Kiora Pharmaceuticals (KPRX) Net Shares Issued and Repurchased (2018 - 2022)

Kiora Pharmaceuticals (KPRX) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $260500.0 the latest figure, recorded in Q1 2022.

• For the quarter ending Q1 2022, Net Shares Issued and Repurchased rose 99.06% year-over-year to $260500.0; the trailing twelve-month figure through Mar 2022 stood at $260500.0 (up 99.06% YoY), and the FY2021 full-year result was $345865.0, up 271.24% from the prior year.
• Net Shares Issued and Repurchased declined to $260500.0 in Q1 2022 per KPRX's latest filing, from $345865.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $345865.0 in Q4 2021 and bottomed at $3237.0 in Q1 2019.
• Historically, Net Shares Issued and Repurchased has averaged $120015.9 across 5 years, with a median of $93165.0 in 2020.
• The sharpest annual moves came in 2020 and 2021: Net Shares Issued and Repurchased jumped 2237.5% in 2020, then soared 72.95% in 2021.
• Over 5 years, Net Shares Issued and Repurchased stood at $27687.0 in 2018, then soared by 80.57% to $49994.0 in 2019, then surged by 86.35% to $93165.0 in 2020, then soared by 271.24% to $345865.0 in 2021, then retreated by 24.68% to $260500.0 in 2022.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $260500.0, $345865.0, and $130865.0 for Q1 2022, Q4 2021, and Q1 2021 respectively.